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1726-4ReplyTo the Editor,
We thank Dr. €Ozdemir for his careful reading of our article,
and pointing out some of the probiotics' effects on mechanisms
affecting allergy development such as their direct effect on
maturing gut barrier (intestinal mucosa structure/function) and
development of tolerogenic dendritic cells resulting in trans-
formation of the local intestinal and systemic immune
response.1,2 These favorable effects elicited by probiotics in
allergic children are consistent with the current concept of
nutritional immunology, explaining not only the treatment of
allergic symptoms but also developing tolerance. Quite a few
studies have demonstrated the role that probiotics play in relation
to allergic airway diseases such as asthma and allergic rhinitis
(AR); in those studies, pulmonary function and clinical symptom
scores for asthma and AR improved, and a significant change in
blood and/or immunologic parameters of AR patients supple-
mented with probiotics were additionally demonstrated.1,2 We
concluded that probiotics have shown more promise, albeit
limited, in the primary prevention of allergic disease rather than
in the treatment of established disease.3 Recently, data from the
PubMed database and published studies indicate that prebiotics,
probiotics, or synbiotics intake improved quality of life score in
patients with allergic conditions.4 However, it was noted that
markedly differing heterogeneity between studies made direct
comparison difficult. Most apparently, there was no significant
change in blood or immunologic parameters in the probiotic
group. This suggests that probiotics may be useful in allergic
disease, but the present data is not sufficient to allow for any
treatment recommendations,4e6 and insufficient to support any
assumed safety of probiotic use in healthy newborns.1 Other
organizations support this treatment reservation at the present
time. The ESPGHAN Committee on Nutrition is concerned that
the available data are not sufficient to support the safety of pro-
biotics in healthy newborns and very young infants with imma-
ture defense systems, infants with immunocompromised
systems, premature infants, and infants with congenital heart
disease.7 Dietary supplements with probiotic effects have been
reported to reduce the incidence of necrotizing enterocolitis and
all-cause mortality in preterm infants.8 However, there is an
enhanced sense of need for extra precautions to be followedwhencts of interest: The authors declare that there are no conflicts of interest
to the subject matter or materials discussed in this article.
x.doi.org/10.1016/j.jcma.2015.08.001
901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Assusing probiotics in immunocompromised patients, including
premature infants, due to an increased risk of adverse effects and,
in rare cases, infection caused by fungal contamination.9,10
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